Hikma, the London-listed generic
drugmaker, has sharply increased the price of a string of medicines in the US — including
a diarrhoea treatment that has risen 430 per cent — in the latest instance of
您已阅读9%（198字），剩余91%（2059字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。